Updated:
MedTex Ventures
Venture capital firm focused on early stage medical devices | MedTex Ventures is a venture capital firm focused on early stage medical devices.
MedTex Ventures
Venture capital firm focused on early stage medical devices | MedTex Ventures is a venture capital firm focused on early stage medical devices. Our team consists of expert investors with a diverse set of backgrounds representing the buy-side, sell-side, and medical device industry. We have partnered with Biotex, Inc. to help source, analyze, develop, and manage medical device companies that MedTex invests in.
General information
Firm type
Venture Capital
Year founded
2021
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Norwalk
Corporate office
119 Rowayton Ave, Norwalk, CT 06853, United States
Additional offices
Houston, TX, United States (Biotex Office)
Sector focus
Frequently asked questions
How does MedTex Ventures source its deals?
MedTex sources almost exclusively through Biotex, a Houston-based medical device development accelerator with more than 20 years of experience in medical device manufacturing and commercialization. Biotex works with companies at the prototype stage, and MedTex evaluates those same companies for investment, giving it a pipeline of start-ups that have already been screened for engineering feasibility. This integrated sourcing model is the defining feature of the firm’s strategy.
What investment stages does MedTex target?
MedTex focuses on pre-Series A medical device companies. Its public materials specify that it looks for functional prototypes, strong intellectual property, and defined reimbursement pathways. The firm has also indicated an interest in buyout opportunities within medical devices, though its primary mandate is early-stage venture.
Is MedTex Ventures a single-family office or an independent venture firm?
MedTex is structured as an investment advisory firm, not a single-family office. It raises capital from high-net-worth individuals, family offices, financial advisors, and institutions, all of whom must be Qualified Clients. The firm is exempt from SEC registration and operates as a Connecticut-based investment adviser.
What is the relationship between MedTex Ventures and Biotex?
Biotex functions as MedTex’s operating partner, providing the technical capabilities to source, analyze, develop, and manage the medical device companies MedTex invests in. Biotex has its own office in Houston and a 20-year track record in medical device product development. The two entities share a deeply integrated workflow, meaning the same team that accelerates a device’s development also informs MedTex’s investment decisions.
Does MedTex invest in digital health or biopharma?
No. MedTex explicitly restricts its investments to medical devices — hardware-based medical technology. It does not pursue digital health, diagnostics, or biopharma opportunities, which distinguishes it from broad healthcare venture funds.
What type of investors can access MedTex Ventures’ funds?
MedTex serves high-net-worth individuals, family offices, financial advisors, and institutions. All investors must meet the definition of Qualified Client under the Investment Advisers Act of 1940, which typically requires a minimum net worth or assets-under-management threshold.
Has MedTex disclosed any specific portfolio companies?
No. As of the latest available information, MedTex does not publicly name any portfolio companies on its website or in regulatory filings. All information about its holdings remains private.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: